We are live on
!
Find out more
ASP
Adams Street Partners Portfolio holdings
AUM
$260M
1-Year Est. Return
30.38%
This Fund
S&P 500
This Quarter
Est. Return
+12.52%
1 Year Est. Return
+30.38%
3 Year Est. Return
+351.96%
5 Year Est. Return
+202.05%
10 Year Est. Return
+1,159.77%
AUM
$392M
AUM Growth
-$34.7M
(-8.1%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-20.02%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
17
New
4
Increased
–
Reduced
2
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRISPR Therapeutics
CRSP
|
+$1.03M |
| 2 |
Diamondback Energy
FANG
|
+$393K |
| 3 |
MITL
Mitel Networks Corporation
MITL
|
+$69.1K |
| 4 |
Sunrun
RUN
|
+$45K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paylocity
PCTY
|
+$53.6M |
| 2 |
Box
BOX
|
+$13.6M |
| 3 |
MOMO
Hello Group
MOMO
|
+$5.37M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$1.76M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$1.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 83.38% |
| 2 | Healthcare | 16.51% |
| 3 | Energy | 0.11% |
| 4 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Paylocity
PCTY
$6.71B
| $183M | 46.72% |
3,747,128
-1,155,000
| -24% | -$53.6M |
|
2
Q2 Holdings
QTWO
$3.42B
| $143M | 36.63% |
3,443,275
| – | – |
|
3
Corvus Pharmaceuticals
CRVS
$1.1B
| $42.8M | 10.94% |
2,687,381
| – | – |
|
|
CALL
4
DELISTED
magicJack VocalTec Ltd
CALL
| $14.1M | 3.61% |
1,976,861
| – | – |
|
|
OMED
5
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $6.66M | 1.7% |
1,473,061
-366,669
| -20% | -$1.49M |
|
|
6
CRISPR Therapeutics
CRSP
$4.58B
| $1.02M | 0.26% |
+57,028
| New | +$1.03M |
|
|
7
Diamondback Energy
FANG
$57.6B
| $418K | 0.11% |
+4,272
| New | +$393K |
|
|
MITL
8
DELISTED
Mitel Networks Corporation
MITL
| $73K | 0.02% |
+8,696
| New | +$69.1K |
|
|
9
Sunrun
RUN
$2.37B
| $37K | 0.01% |
+6,600
| New | +$45K |
|
|
10
Box
BOX
$4.02B
| – | – |
-746,568
| Closed | -$13.6M |
|
|
MOMO
11
Hello Group
MOMO
$869M
| – | – |
-145,400
| Closed | -$5.37M |
|
12
Senseonics Holdings Inc
SENS
$254M
| – | – |
-32,602
| Closed | -$1.17M |
|
13
Varonis Systems
VRNS
$5.25B
| – | – |
-13,152
| Closed | -$163K |
|
|
TBRG
14
DELISTED
TruBridge
TBRG
| – | – |
-7,972
| Closed | -$261K |
|
|
NEWR
15
DELISTED
New Relic, Inc.
NEWR
| – | – |
-22,191
| Closed | -$954K |
|
|
CLVS
16
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-18,785
| Closed | -$1.76M |
|
|
ZEN
17
DELISTED
ZENDESK INC
ZEN
| – | – |
-55,258
| Closed | -$1.53M |
|
Similar funds
MA
LIM
WI
SHCM
BOC
LCM
ICM
HIA
Adams Street Partners's Q3 2017 Portfolio in Review
As of Q3 2017, Adams Street Partners held 17 positions worth $392M, down 8.1% from $426M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Adams Street Partners withdrew a net $78.4M in Q3 2017, closing 8 positions and reducing 2 holdings. Its most notable exit was Box, an estimated $13.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 83% of assets, down from 85% a quarter earlier, followed by Healthcare and Energy.
Against the trend, Adams Street Partners opened a new position in CRISPR Therapeutics worth $1.02M.
- Adams Street Partners's largest Q3 2017 buy was CRISPR Therapeutics: 57,028 shares worth $1.02M.
- Adams Street Partners's biggest Q3 2017 reduction was Paylocity, cutting an estimated $53.6M.
- Adams Street Partners fully exited Box in Q3 2017, selling an estimated $13.6M.
- Adams Street Partners's ten largest holdings make up 100% of its $392M portfolio in Q3 2017.
- Adams Street Partners opened 4 new positions and closed 8 in Q3 2017.
- Adams Street Partners's portfolio value fell 8.1% quarter-over-quarter to $392M.
Based on Adams Street Partners's 13F filing for Q3 2017, filed 13 Nov 2017.